Search research articles
Contact Us
Filters
Showing results (11-20 of 420) with videos related to
Page
of 42
Sort By:
Frontiers in Pharmacology
|
July 31, 2023
Neuroprotection afforded by targeting G protein-coupled receptors in heteromers and by heteromer-selective drugs
Rafael Franco, Gemma Navarro
Frontiers in Neurology
|
October 27, 2015
Suggesting a Way to Understand the Actual Potential of Anti-Alzheimer's Disease Drugs That Show Promise in Transgenic Mouse Models
Rafael Franco, Milos Petrovic
Current Opinion in Pharmacology
|
December 18, 2009
Oligomerization of G-protein-coupled receptors: a reality
Sergi Ferré, Rafael Franco
Frontiers in Psychiatry
|
March 30, 2018
Adenosine A<sub>2A</sub> Receptor Antagonists in Neurodegenerative Diseases: Huge Potential and Huge Challenges
Rafael Franco, Gemma Navarro
Frontiers in Genetics
|
July 24, 2019
Editorial: Epigenetics in Mammalian Tissues
Rafael Franco, Michael E Symonds
Frontiers in Pharmacology
|
July 11, 2014
Successful therapies for Alzheimer's disease: why so many in animal models and none in humans?
Rafael Franco, Angel Cedazo-Minguez
Food Chemistry
|
May 31, 2017
Chemical rules on the assessment of antioxidant potential in food and food additives aimed at reducing oxidative stress and neurodegeneration
Rafael Franco, Eva Martínez-Pinilla
Progress in Neurobiology
|
June 13, 2015
Alternatively activated microglia and macrophages in the central nervous system
Rafael Franco, Diana Fernández-Suárez
Biomedicines
|
May 28, 2022
Robustness of the Krebs Cycle under Physiological Conditions and in Cancer: New Clues for Evaluating Metabolism-Modifying Drug Therapies
Rafael Franco, Joan Serrano-Marín
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology
|
December 22, 2022
The unbroken Krebs cycle. Hormonal-like regulation and mitochondrial signaling to control mitophagy and prevent cell death
Rafael Franco, Joan Serrano-Marín
Page
of 42
Search research articles
Search
Showing results (11-20 of 420) with videos related to
Sort By:
Page
of 42
Frontiers in Pharmacology
|
July 31, 2023
Neuroprotection afforded by targeting G protein-coupled receptors in heteromers and by heteromer-selective drugs
Rafael Franco, Gemma Navarro
Frontiers in Neurology
|
October 27, 2015
Suggesting a Way to Understand the Actual Potential of Anti-Alzheimer's Disease Drugs That Show Promise in Transgenic Mouse Models
Rafael Franco, Milos Petrovic
Current Opinion in Pharmacology
|
December 18, 2009
Oligomerization of G-protein-coupled receptors: a reality
Sergi Ferré, Rafael Franco
Frontiers in Psychiatry
|
March 30, 2018
Adenosine A<sub>2A</sub> Receptor Antagonists in Neurodegenerative Diseases: Huge Potential and Huge Challenges
Rafael Franco, Gemma Navarro
Frontiers in Genetics
|
July 24, 2019
Editorial: Epigenetics in Mammalian Tissues
Rafael Franco, Michael E Symonds
Frontiers in Pharmacology
|
July 11, 2014
Successful therapies for Alzheimer's disease: why so many in animal models and none in humans?
Rafael Franco, Angel Cedazo-Minguez
Food Chemistry
|
May 31, 2017
Chemical rules on the assessment of antioxidant potential in food and food additives aimed at reducing oxidative stress and neurodegeneration
Rafael Franco, Eva Martínez-Pinilla
Progress in Neurobiology
|
June 13, 2015
Alternatively activated microglia and macrophages in the central nervous system
Rafael Franco, Diana Fernández-Suárez
Biomedicines
|
May 28, 2022
Robustness of the Krebs Cycle under Physiological Conditions and in Cancer: New Clues for Evaluating Metabolism-Modifying Drug Therapies
Rafael Franco, Joan Serrano-Marín
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology
|
December 22, 2022
The unbroken Krebs cycle. Hormonal-like regulation and mitochondrial signaling to control mitophagy and prevent cell death
Rafael Franco, Joan Serrano-Marín
Page
of 42